Nature News

Air sampling reveals high emissions from gas field

Nature 482, 139 07022012 doi: 10.1038/482139a

Jeff Tollefson

Methane leaks during production may offset climate benefits of natural gas.

Drug bests cystic-fibrosis mutation

Nature 482, 145 07022012 doi: 10.1038/482145a

Heidi Ledford

First treatment to tackle protein behind the disease wins approval — but only a small fraction of patients will benefit.

Duplicate-grant case puts funders under pressure

Nature 482, 146 07022012 doi: 10.1038/482146a

Eugenie Samuel Reich

Critics call for tighter checks to stop researchers being funded twice for the same work.

Experimental project gives big pharma its youth back

Nature News , 07022012 doi: 10.1038/nature.2012.9979

Heidi Ledford

GlaxoSmithKline's Discovery Performance Units strive to provide the advantages of a smaller company.

Europe experiments with joined-up research

Nature News , 07022012 doi: 10.1038/nature.2012.9981

Alison Abbott

First Joint Programme announces its research strategy.

‘Too soon’ to confirm success of Antarctic lake drilling

Nature News , 07022012 doi: 10.1038/nature.2012.9986

Daniel Cressey

Lake Vostok project leader says more analysis needed to verify lake has been reached.

Higgs signal gains strength

Nature News , 07022012 doi: 10.1038/nature.2012.9992

Geoff Brumfiel

Latest analyses from the Large Hadron Collider boosts case for particle.

Fission power back on NASA’s agenda

Nature 482, 141 06022012 doi: 10.1038/482141a

Eric Hand

Space-technology report prioritizes nuclear propulsion.

US environment agency misses dioxin deadline

Nature News , 06022012 doi: 10.1038/nature.2012.9975

Brendan Borrell

Academia and industry unite to criticize delays in publishing regulatory guidelines.

Minnesota starts to destroy stored blood spots

Nature News , 03022012 doi: 10.1038/nature.2012.9971

Meredith Wadman

Court ruling that the state must get consent to store samples from newborn screening could hinder biomedical research.

Isotopes hint at North Korean nuclear test

Nature News , 03022012 doi: 10.1038/nature.2012.9972

Geoff Brumfiel

Data suggest that the country has experimented with a fusion boost to its fission weapons.

Europe's research plan starts to take shape

Nature News , 03022012 doi: 10.1038/nature.2012.9973

Lucas Laursen

Teresa Riera Madurell describes her goals for the Horizon 2020 funding programme.

Malaria death toll disputed

Nature News , 03022012 doi: 10.1038/nature.2012.9974

Zoe Cormier

Study doubles official estimate, but scientists say its methods are flawed.

Norway to bring cancer-gene tests to the clinic

Nature News , 02022012 doi: 10.1038/nature.2012.9949

Ewen Callaway

A pilot programme will use latest tumour-sequencing techniques to help guide cancer care.

Researchers feel pressure to cite superfluous papers

Nature News , 02022012 doi: 10.1038/nature.2012.9968

Richard Van Noorden

First survey to quantify problem finds that junior faculty are more likely to be targeted.

One genome from many

Nature News , 02022012 doi: 10.1038/nature.2012.9969

Virginia Gewin

Researchers extract genome for single organism from water sample.

Questions hang over red-wine chemical

Nature News , 02022012 doi: 10.1038/nature.2012.9970

Ewen Callaway

How resveratrol benefits health a matter of debate.

Global health hits crisis point

Nature 482, 7 01022012 doi: 10.1038/482007a

Laurie Garrett

The Global Fund's drive to ensure sustainability and efficiency means that it may not be able to meet its commitments to combat disease, says Laurie Garrett.

Seven days: 27 January–2 February 2012

Nature 482, 10 01022012 doi: 10.1038/482010a

The week in science: sequencing stock rebounds after takeover bid for Illumina; drug companies and nations team up against neglected diseases; and turmoil at the Global Fund.

Genomics ace quits Japan

Nature 482, 18 01022012 doi: 10.1038/482018a

David Cyranoski

Yusuke Nakamura blames government inertia for his move to the United States.